Jazz Pharmaceuticals Operating Margin 2007-2019 | JAZZ

Current and historical operating margin for Jazz Pharmaceuticals (JAZZ) over the last 10 years. The current operating profit margin for Jazz Pharmaceuticals as of December 31, 2019 is 38.87%.
Jazz Pharmaceuticals Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2019-12-31 $2.16B $0.53B 24.61%
2019-09-30 $2.06B $0.66B 31.91%
2019-06-30 $1.99B $0.71B 35.83%
2019-03-31 $1.95B $0.66B 33.85%
2018-12-31 $1.89B $0.62B 32.54%
2018-09-30 $1.85B $0.57B 30.86%
2018-06-30 $1.79B $0.47B 26.10%
2018-03-31 $1.69B $0.48B 28.45%
2017-12-31 $1.62B $0.53B 32.63%
2017-09-30 $1.58B $0.55B 35.02%
2017-06-30 $1.54B $0.60B 39.13%
2017-03-31 $1.53B $0.61B 39.73%
2016-12-31 $1.49B $0.59B 39.78%
2016-09-30 $1.43B $0.53B 37.22%
2016-06-30 $1.40B $0.53B 37.81%
2016-03-31 $1.35B $0.51B 37.94%
2015-12-31 $1.33B $0.51B 38.42%
2015-09-30 $1.31B $0.53B 40.55%
2015-06-30 $1.28B $0.46B 35.84%
2015-03-31 $1.24B $0.38B 30.69%
2014-12-31 $1.17B $0.20B 16.62%
2014-09-30 $1.08B $0.16B 14.71%
2014-06-30 $1.01B $0.20B 20.08%
2014-03-31 $0.92B $0.21B 22.21%
2013-12-31 $0.87B $0.34B 38.99%
2013-09-30 $0.82B $0.31B 38.17%
2013-06-30 $0.76B $0.27B 34.95%
2013-03-31 $0.68B $0.23B 33.68%
2012-12-31 $0.59B $0.20B 33.56%
2012-09-30 $0.49B $0.17B 34.50%
2012-06-30 $0.38B $0.15B 38.28%
2012-03-31 $0.33B $0.14B 43.69%
2011-12-31 $0.27B $0.13B 47.25%
2011-09-30 $0.24B $0.12B 48.35%
2011-06-30 $0.21B $0.10B 45.33%
2011-03-31 $0.19B $0.07B 39.15%
2010-12-31 $0.17B $0.06B 33.53%
2010-09-30 $0.16B $0.04B 27.22%
2010-06-30 $0.14B $0.03B 22.92%
2010-03-31 $0.14B $0.03B 21.28%
2009-12-31 $0.13B $0.02B 12.50%
2009-09-30 $0.11B $-0.05B -42.73%
2009-06-30 $0.10B $-0.08B -81.44%
2009-03-31 $0.08B $-0.13B -176.32%
2008-12-31 $0.07B $-0.17B -247.83%
2008-09-30 $0.06B $-0.18B -278.13%
2008-06-30 $0.07B $-0.17B -250.75%
2008-03-31 $0.07B $-0.16B -252.31%
2007-12-31 $0.06B $-0.14B -217.19%
2007-06-30 $0.04B $-0.08B -212.82%
2007-03-31 $0.04B $-0.06B -169.44%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.655B $2.162B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.999B 32.39
Takeda Pharmaceutical (TAK) Japan $47.260B 8.28
Astellas Pharma (ALPMY) Japan $27.822B 13.90
Eisai (ESALY) Japan $20.849B 38.84
Grifols, S.A (GRFS) Spain $13.421B 16.68
Merck (MKGAF) Germany $12.451B 16.33
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.539B 237.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.384B 30.38
Ionis Pharmaceuticals (IONS) United States $6.926B 20.99
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.299B 0.00
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.549B 0.00
IPSEN SA ADR (IPSEY) France $4.173B 0.00
United Therapeutics (UTHR) United States $4.038B 0.00
Hypermarcas (HYPMY) Brazil $3.970B 12.08
Evotec AG (EVTCY) Germany $3.485B 56.21
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 57.72
Nektar Therapeutics (NKTR) United States $3.109B 0.00
FibroGen (FGEN) United States $2.976B 0.00
PTC Therapeutics (PTCT) United States $2.720B 0.00
ChemoCentryx (CCXI) United States $2.460B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.375B 9.61
Xencor (XNCR) United States $1.725B 70.44
Sage Therapeutics (SAGE) United States $1.607B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.595B 19.39
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Karyopharm Therapeutics (KPTI) United States $1.392B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.364B 37.29
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.261B 14.10
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.084B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.032B 14.38
Esperion Therapeutics (ESPR) United States $1.029B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.991B 30.69
Akebia Therapeutics (AKBA) United States $0.977B 0.00
Endo (ENDP) Ireland $0.855B 1.58
Tilray (TLRY) Canada $0.822B 0.00
Radius Health (RDUS) United States $0.666B 0.00
Molecular Templates (MTEM) United States $0.658B 0.00
Aerie Pharmaceuticals (AERI) United States $0.627B 0.00
ImmunoGen (IMGN) United States $0.617B 0.00
Translate Bio (TBIO) United States $0.615B 0.00
Collegium Pharmaceutical (COLL) United States $0.583B 0.00
Portola Pharmaceuticals (PTLA) United States $0.551B 0.00
Indivior (INVVY) United States $0.509B 3.03
Corbus Pharmaceuticals Holdings (CRBP) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.402B 13.41
Ardelyx (ARDX) United States $0.395B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.390B 15.99
Innate Pharma SA (IPHYF) France $0.385B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.385B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Organogenesis Holdings (ORGO) United States $0.373B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
TherapeuticsMD (TXMD) United States $0.350B 0.00
Flexion Therapeutics (FLXN) United States $0.337B 0.00
Trillium Therapeutics (TRIL) Canada $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
DURECT (DRRX) United States $0.294B 0.00
Lannett Co Inc (LCI) United States $0.291B 4.69
Calithera Biosciences (CALA) United States $0.289B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.273B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.270B 0.00
Ocular Therapeutix (OCUL) United States $0.257B 0.00
CASI Pharmaceuticals (CASI) United States $0.222B 0.00
OptiNose (OPTN) United States $0.191B 0.00
Rafael Holdings (RFL) United States $0.189B 0.00
Recro Pharma (REPH) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 22.15
MEI Pharma (MEIP) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.07
PROFOUND MEDICL (PROF) Canada $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.154B 0.00
KalVista Pharmaceuticals (KALV) United States $0.137B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Taiwan Liposome (TLC) Taiwan $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.106B 0.00
CannTrust Holdings (CTST) Canada $0.105B 0.00
Redhill Biopharma (RDHL) Israel $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Xeris Pharmaceuticals (XERS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
CV Sciences (CVSI) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
Aquestive Therapeutics (AQST) United States $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Otonomy (OTIC) United States $0.063B 0.00
Hemispherx BioPharma (AIM) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
PharmAthene (ALT) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
PolarityTE (PTE) United States $0.048B 0.00
MediWound (MDWD) Israel $0.046B 0.00
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 19.19
AgeX Therapeutics (AGE) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.29
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
IsoRay (ISR) United States $0.039B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
India Globalization Capital (IGC) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.024B 7.55
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Novan (NOVN) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
ElectroCore (ECOR) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00